Home / Intelligence / Webinars / Artificial Intelligence & Machine Learning 101
Available On Demand
You have likely heard all the buzz around Artificial Intelligence and Machine Learning (AIML), but what does it really mean? It’s time to cut through the complexity during Trinity Life Sciences’ AIML 101 webinar.
This webinar is designed for the AIML novice, who knows very little about the topic but doesn’t want to be left behind.
AIML is here. Be ready with Trinity.
Key Webinar Topics
- What is Artificial Intelligence? What is Machine Learning? Are they different?
- We’ll demystify how AIML algorithms are made.
- What is all the hype with ChatGPT?
- What are some real-life use cases, especially in pharma commercial operations?
- Get up to speed on the latest AIML terminology.
Featuring
Complete the form below to view the on-demand webinar.
By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.
This webinar will be hosted within the ON24 platform, which requires the usage of Javascript and Cookies. Please see ON24’s Privacy Policy for more information.
*Gartner, Hype Cycle for Life Sciences Commercial Operations, Animesh Gandhi, published 13 August 2024.
GARTNER is a registered trademark and service mark of Gartner and Hype Cycle is a registered trademark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission. All rights reserved.
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
Related Intelligence
Blog
Operationalizing Generative AI in Life Sciences—Trinity Life Sciences Included in Everest Group Report
The transformative potential of generative AI (GenAI) within the life sciences industry is highlighted in Everest Group’s report, “AI-deas to Action: Operationalizing Generative AI in Life Sciences.” Fifteen companies were selected for inclusion across three categories: To be included in the report, providers had to have been profiled in past Everest Group PEAK Matrix® […]
Read More
Analyst Reports
Everest Group recognizes Trinity Life Sciences as a Featured Specialist in Operationalizing Generative AI in Life Sciences
Everest Group report: AI-deas to Action: Operationalizing Generative AI in Life Sciences This research report provides a comprehensive analysis of how generative AI (GenAI) is being operationalized in the life sciences industry and assesses the capabilities of the fifteen vendors included. The report highlights several of Trinity’s key strengths, including: Life Sciences Industry Expertise Trinity […]
Read More
Webinars
Generative AI in Pharma – Five Years From Now
Available On Demand
Generative AI is having a transformative impact on the pharmaceutical industry. Drugmakers are partnering up with companies like Insilico Medicine, Exscientia, BenevolentAI, and more to leverage their respective generative AI-powered platforms and applying them across the pharma value chain: from accelerating drug discovery and optimizing clinical trials, to improving operational efficiencies and enabling personalized treatments […]
Watch Now